AMIKACIN SULFATE INJECTION, USP, 1 gram/4 mL (250 mg/ml), 4 mL vial, Rx only, Mfd. by: Emcure Pharmaceuticals, Ltd., Hinjawadi, Pune, India Mfd. for: Heritage Pharmaceuticals Inc.. NDC 23155-290-32
Published June 19, 2019 · Recall initiated: May 21, 2019
Summary
FDA records drug Class I recall D-1398-2019, published June 19, 2019 and initiated May 21, 2019. Recalling firm: Heritage Pharmaceuticals, Inc.; Status: Terminated; Reported quantity: 14,960 4 mL vials; Lot: Lot: VEAC025, EXP 10-2019. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Non-Sterility:Microbial growth detected in sub lot of Amikacin Sulfate Injection, USP 1gm/4 mL (250mg/mL) and Prochlorperazine Edisylate Injection, USP 10mg/2mL (5mg/mL) .
What to do
Voluntary: Firm initiated · Press Release
Get an email if AMIKACIN SULFATE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- AMIKACIN SULFATE
- Manufacturer
- Heritage Pharmaceuticals, Inc.
- Distributor
- Nationwide in the USA
- UPC
- 0323155290325
- Lot
- Lot: VEAC025, EXP 10-2019
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAPecgen DMX Cough Suppressant Expectorant, Contains the same active ingredients as Trispec DMX, Sugar Free,June 19, 2019
- FDASn-d, l-Exametazime (Sn-d,l-HMPAO), Not for Direct Injection, Store Below 25 C, Synthetopes, Inc.June 19, 2019
- FDAHydrocodone Bitartrate and Homatropine Methylbromide Oral Solution, 5 mg/1.5 mg per 5 mL, Rx Only, 16 FL. oz.June 19, 2019
- FDASn-DTPA Kit 10 mg, DTPA, Not for Direct Injection, Store at Room Temperature, Synthetopes, Inc.June 19, 2019
- FDAHydrocodone Bitartrate and Homatropine Methylbromide Oral Solution, 5 mg/1.5 mg per 5 mL, Rx Only, 16 FL. oz.June 19, 2019
- FDASn-Tetrofosmin Kit 5.0 mL, Thaw and Vent before use, Not for Direct Injection, Store Frozen, Synthetopes, Inc.June 19, 2019
Questions about this recall
Was AMIKACIN SULFATE INJECTION, USP, 1 gram/4 mL (250 mg/ml), 4 mL vial, Rx only, Mfd. by: Emcure Pharmaceuticals, Ltd., Hinjawadi, Pune, India Mfd. for: Heritage Pharmaceuticals Inc.. NDC 23155-290-32 recalled?
Yes. FDA published recall D-1398-2019 on June 19, 2019. Reported hazard: Non-Sterility:Microbial growth detected in sub lot of Amikacin Sulfate Injection, USP 1gm/4 mL (250mg/mL) and Prochlorperazine Edisylate Injection, USP 10mg/2mL (5mg/mL) .
What should I do if I have this product?
Voluntary: Firm initiated · Press Release
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: AMIKACIN SULFATE. UPC: 0323155290325.